Literature DB >> 28149774

Neuroprotective effects of BDNF and GDNF in intravitreally transplanted mesenchymal stem cells after optic nerve crush in mice.

Zong-Li Hu1, Ni Li1, Xin Wei1, Li Tang1, Ting-Hua Wang2, Xiao-Ming Chen1.   

Abstract

AIM: To assess the neuro-protective effect of bone marrow mesenchymal stem cells (BMSCs) on retinal ganglion cells (RGCs) following optic nerve crush in mice.
METHODS: C56BL/6J mice were treated with intravitreal injection of PBS, BMSCs, BDNF-interference BMSCs (BIM), and GDNF-interference BMSCs (GIM) following optic nerve crush, respectively. The number of surviving RGCs was determined by whole-mount retinas and frozen sections, while certain mRNA or protein was detected by q-PCR or ELISA, respectively.
RESULTS: The density (cell number/mm2) of RGCs was 410.77±56.70 in the retina 21d after optic nerve crush without any treatment, compared to 1351.39±195.97 in the normal control (P<0.05). RGCs in BMSCs treated eyes was 625.07±89.64/mm2, significantly higher than that of no or PBS treatment (P<0.05). While RGCs was even less in the retina with intravitreal injection of BIM (354.07+39.77) and GIM (326.67+33.37) than that without treatment (P<0.05). BMSCs injection improved the internal BDNF expression in retinas.
CONCLUSION: Optic nerve crush caused rust loss of RGCs and intravitreally transplanted BMSCs at some extent protected RGCs from death. The effect of BMSCs and level of BDNF in retinas are both related to BDNF and GDNF expression in BMSCs.

Entities:  

Keywords:  brain-derived neurotrophic factor; glial cell line-derived neurotrophic factor; optic nerve crush; retinal ganglion cells; stem cells

Year:  2017        PMID: 28149774      PMCID: PMC5225346          DOI: 10.18240/ijo.2017.01.06

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  54 in total

1.  Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study.

Authors:  Guillermo Parrilla-Reverter; Marta Agudo; Paloma Sobrado-Calvo; Manuel Salinas-Navarro; María P Villegas-Pérez; Manuel Vidal-Sanz
Journal:  Exp Eye Res       Date:  2009-03-04       Impact factor: 3.467

2.  Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat.

Authors:  Michael Blair; Mary Ellen Pease; John Hammond; Danielle Valenta; Jennifer Kielczewski; Hana Levkovitch-Verbin; Harry Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

3.  Axons from CNS neurons regenerate into PNS grafts.

Authors:  P M Richardson; U M McGuinness; A J Aguayo
Journal:  Nature       Date:  1980-03-20       Impact factor: 49.962

4.  Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats.

Authors:  Tantai Zhao; Yunqin Li; Luosheng Tang; Yuehua Li; Fang Fan; Bing Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-01       Impact factor: 3.117

5.  Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury.

Authors:  Ben Mead; Ann Logan; Martin Berry; Wendy Leadbeater; Ben A Scheven
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-15       Impact factor: 4.799

6.  Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons.

Authors:  Changgeng Peng; Liviu Aron; Rüdiger Klein; Meng Li; Wolfgang Wurst; Nilima Prakash; Weidong Le
Journal:  J Neurosci       Date:  2011-09-07       Impact factor: 6.167

7.  Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density.

Authors:  Eric Falke; Jonathan Nissanov; Thomas W Mitchell; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina.

Authors:  Minoru Tomita; Yasushi Adachi; Haruhiko Yamada; Kanji Takahashi; Katsuji Kiuchi; Haruki Oyaizu; Kazuya Ikebukuro; Hiroyuki Kaneda; Miyo Matsumura; Susumu Ikehara
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

9.  Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.

Authors:  Simone Iwabe; Norma A Moreno-Mendoza; Francisco Trigo-Tavera; Cheryl Crowder; Gustavo A García-Sánchez
Journal:  Vet Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.644

10.  Effects of the Concomitant Activation of ON and OFF Retinal Ganglion Cells on the Visual Thalamus: Evidence for an Enhanced Recruitment of GABAergic Cells.

Authors:  Giovanni Montesano; Marcello Belfiore; Maddalena Ripamonti; Alessandro Arena; Jacopo Lamanna; Mattia Ferro; Vincenzo Zimarino; Alessandro Ambrosi; Antonio Malgaroli
Journal:  Front Neural Circuits       Date:  2015-11-24       Impact factor: 3.492

View more
  10 in total

Review 1.  Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions.

Authors:  Kimberly K Gokoffski; Micalla Peng; Basheer Alas; Phillip Lam
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

2.  Six-month results of suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with optic atrophy: a phase 1/2 study.

Authors:  Ayse Oner; Zeynep Burcin Gonen; Duygu Gülmez Sevim; Neslihan Sinim Kahraman; Metin Unlu
Journal:  Int Ophthalmol       Date:  2019-07-15       Impact factor: 2.031

Review 3.  Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis.

Authors:  Licheng Li; Yang Yu; Shu Lin; Jianmin Hu
Journal:  Stem Cell Res Ther       Date:  2022-06-07       Impact factor: 8.079

4.  Glial cell line-derived neurotrophic factor (GDNF) in patients with primary open-angle glaucoma and age-related cataract.

Authors:  Alexander A Shpak; Alla B Guekht; Tatiana A Druzhkova; Anna A Troshina; Natalia V Gulyaeva
Journal:  Mol Vis       Date:  2022-05-15       Impact factor: 2.711

5.  Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy.

Authors:  Paolo Giuseppe Limoli; Celeste Limoli; Enzo Maria Vingolo; Federica Franzone; Marcella Nebbioso
Journal:  Stem Cell Res Ther       Date:  2021-05-06       Impact factor: 6.832

Review 6.  Shaping the Microglia in Retinal Degenerative Diseases Using Stem Cell Therapy: Practice and Prospects.

Authors:  Ni Jin; Weiwei Sha; Lixiong Gao
Journal:  Front Cell Dev Biol       Date:  2021-12-13

Review 7.  Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases.

Authors:  Giuliana Mannino; Cristina Russo; Anna Longo; Carmelina Daniela Anfuso; Gabriella Lupo; Debora Lo Furno; Rosario Giuffrida; Giovanni Giurdanella
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

8.  Stem cell therapy for retinal ganglion cell degeneration.

Authors:  Ling-Ping Cen; Tsz Kin Ng
Journal:  Neural Regen Res       Date:  2018-08       Impact factor: 5.135

Review 9.  Regenerative medicine in the retina: from stem cells to cell replacement therapy.

Authors:  Julia Oswald; Petr Baranov
Journal:  Ther Adv Ophthalmol       Date:  2018-04-26

Review 10.  A Review on Mesenchymal Stem Cells for Treatment of Retinal Diseases.

Authors:  Sanjucta Adak; Damaris Magdalene; Saurabh Deshmukh; Dipankar Das; Bithiah Grace Jaganathan
Journal:  Stem Cell Rev Rep       Date:  2021-01-06       Impact factor: 6.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.